Terms: = Liver cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150 AND Treatment
7 results:
1. Multisystem ALK-positive histiocytosis: a multi-case study and literature review.
Liu W; Liu HJ; Wang WY; Tang Y; Zhao S; Zhang WY; Yan JQ; Liu WP
Orphanet J Rare Dis; 2023 Mar; 18(1):53. PubMed ID: 36915094
[TBL] [Abstract] [Full Text] [Related]
2. Clinical research linking Traditional Chinese Medicine constitution types with diseases: a literature review of 1639 observational studies.
Liang X; Wang Q; Jiang Z; Li Z; Zhang M; Yang P; Wang X; Wang Y; Qin Y; Li T; Zhang T; Wang Y; Sun J; Li Y; Luo H; Li L
J Tradit Chin Med; 2020 Aug; 40(4):690-702. PubMed ID: 32744037
[TBL] [Abstract] [Full Text] [Related]
3. Effectiveness and the strategy to treat the side effects of sorafenib administration after transarterial chemoembolization in advanced hepatocellular carcinoma patients.
Zhang K; Sun X; Xie F; Jian W; Li C
J Cancer Res Ther; 2018 Jan; 14(1):196-200. PubMed ID: 29516985
[TBL] [Abstract] [Full Text] [Related]
4. Prediction model for non-curative resection of endoscopic submucosal dissection in patients with early gastric cancer.
Kim EH; Park JC; Song IJ; Kim YJ; Joh DH; Hahn KY; Lee YK; Kim HY; Chung H; Shin SK; Lee SK; Lee YC
Gastrointest Endosc; 2017 May; 85(5):976-983. PubMed ID: 27756614
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of liver resection for hepatocellular carcinoma in liver transplantation era.
Lee WC; Lee CF; Cheng CH; Wu TJ; Chou HS; Wu TH; Soong RS; Chan KM; Yu MC; Chen MF
Eur J Surg Oncol; 2015 Sep; 41(9):1144-52. PubMed ID: 26163047
[TBL] [Abstract] [Full Text] [Related]
6. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.
Kurtzberg J; Prockop S; Teira P; Bittencourt H; Lewis V; Chan KW; Horn B; Yu L; Talano JA; Nemecek E; Mills CR; Chaudhury S
Biol Blood Marrow Transplant; 2014 Feb; 20(2):229-35. PubMed ID: 24216185
[TBL] [Abstract] [Full Text] [Related]
7. Multimodality treatment in advanced primary liver cancer.
Zhou XD; Tang ZY; Yu YQ; Yang BH; Lu JZ; Lin ZY; Ma ZC
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():286-9. PubMed ID: 7544966
[TBL] [Abstract] [Full Text] [Related]
